Washington DC 20549

 

 

 

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 AND 15d-16 OF

THE SECURITIES EXCHANGE ACT OF 1934

 

 

For 25 July 2025

 

 

(Registrant's name)

 

 

1 Windsor Dials, Arthur Road, Windsor, SL4 1RS, United Kingdom

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

 

Form 20-F           Form 40-F

 

 

 

 

 

99.1	Transaction in Own Shares dated 17 July 2025
99.2	Transaction in Own Shares dated 18 July 2025
99.3	Transaction in Own Shares dated 21 July 2025
99.4	Transaction in Own Shares dated 22 July 2025
99.5	Transaction in Own Shares dated 24 July 2025
99.6	Transaction in Own Shares dated 25 July 2025

 

 

 

 

 

Exhibit No: 99.1

 

17 July 2025

 

 

 

 

The Company announces that on 16 July 2025 it purchased the following number of its ordinary shares of 20340/399 pence each from Merrill Lynch International ("MLI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 18 February 2025 as announced on 18 February 2025.

 

 

Date of Purchase: 16 July

 

	London Stock Exchange	Cboe BXE	Cboe CXE	Turquoise	Aquis
Number of ordinary shares purchased	25,846	0	0	0	0
Highest price paid (per ordinary share)	£ 86.8200	£ 0.0000	£ 0.0000	£ 0.0000	£ 0.0000
Lowest price paid (per ordinary share)	£ 86.2400	£ 0.0000	£ 0.0000	£ 0.0000	£ 0.0000
Volume weighted average price paid (per ordinary share)	£ 86.4183	£ 0.0000	£ 0.0000	£ 0.0000	£ 0.0000

 

 

 

Following the above transaction, the Company has 154,609,375 ordinary shares in issue (excluding 6,206,782 held in treasury).

 

http://www.rns-pdf.londonstockexchange.com/rns/3931R_1-2025-7-16.pdf 

 

 

 

 

 

 

 

 

Shares purchased:        25,846 (ISIN: GB00BHJYC057)

 

Date of Purchases:       16 July 2025

 

 

 

Exhibit No: 99.2

 

 

18 July 2025

 

 

 

 

The Company announces that on 17 July 2025 it purchased the following number of its ordinary shares of 20340/399 pence each from Merrill Lynch International ("MLI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 18 February 2025 as announced on 18 February 2025.

 

 

Date of Purchase: 17 July

 

	London Stock Exchange	Cboe BXE	Cboe CXE	Turquoise	Aquis
Number of ordinary shares purchased	46,781	0	0	0	0
Highest price paid (per ordinary share)	£ 86.6800	£ 0.0000	£ 0.0000	£ 0.0000	£ 0.0000
Lowest price paid (per ordinary share)	£ 84.7800	£ 0.0000	£ 0.0000	£ 0.0000	£ 0.0000
Volume weighted average price paid (per ordinary share)	£ 85.7102	£ 0.0000	£ 0.0000	£ 0.0000	£ 0.0000

 

 

 

Following the above transaction, the Company has 154,562,594 ordinary shares in issue (excluding 6,206,782 held in treasury).

 

 

http://www.rns-pdf.londonstockexchange.com/rns/5759R_1-2025-7-17.pdf 

 

 

 

 

 

 

 

 

Shares purchased:        46,781 (ISIN: GB00BHJYC057)

 

Date of Purchases:       17 July 2025

 

 

 

Exhibit No: 99.3

 

21 July 2025

 

 

 

 

The Company announces that on 18 July 2025 it purchased the following number of its ordinary shares of 20340/399 pence each from Merrill Lynch International ("MLI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 18 February 2025 as announced on 18 February 2025.

 

 

Date of Purchase: 18 July

 

	London Stock Exchange	Cboe BXE	Cboe CXE	Turquoise	Aquis
Number of ordinary shares purchased	34,365	0	0	0	0
Highest price paid (per ordinary share)	£ 86.2600	£ 0.0000	£ 0.0000	£ 0.0000	£ 0.0000
Lowest price paid (per ordinary share)	£ 85.3400	£ 0.0000	£ 0.0000	£ 0.0000	£ 0.0000
Volume weighted average price paid (per ordinary share)	£ 85.8009	£ 0.0000	£ 0.0000	£ 0.0000	£ 0.0000

 

 

 

Following the above transaction, the Company has 154,528,229 ordinary shares in issue (excluding 6,206,782 held in treasury).

 

 

http://www.rns-pdf.londonstockexchange.com/rns/7537R_1-2025-7-18.pdf 

 

 

 

 

Investor Relations:         Stuart Ford (+44 (0)7823 828 739); Kate Carpenter (+44 (0) 7825 655 702); Simpson (+44 (0)7976 862 072)

 

 

 

Shares purchased:        34,365 (ISIN: GB00BHJYC057)

 

Date of Purchases:       18 July 2025

 

 

 

Exhibit No: 99.4

 

22 July 2025

 

 

 

 

The Company announces that on 21 July 2025 it purchased the following number of its ordinary shares of 20340/399 pence each from Merrill Lynch International ("MLI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 18 February 2025 as announced on 18 February 2025.

 

 

Date of Purchase: 21 July

 

	London Stock Exchange	Cboe BXE	Cboe CXE	Turquoise	Aquis
Number of ordinary shares purchased	21,015	0	0	0	0
Highest price paid (per ordinary share)	£ 86.3000	£ 0.0000	£ 0.0000	£ 0.0000	£ 0.0000
Lowest price paid (per ordinary share)	£ 85.8600	£ 0.0000	£ 0.0000	£ 0.0000	£ 0.0000
Volume weighted average price paid (per ordinary share)	£ 86.0421	£ 0.0000	£ 0.0000	£ 0.0000	£ 0.0000

 

 

 

Following the above transaction, the Company has 154,507,214 ordinary shares in issue (excluding 6,206,782 held in treasury).

 

 

http://www.rns-pdf.londonstockexchange.com/rns/9554R_1-2025-7-21.pdf 

 

 

 

 

 

 

 

 

Shares purchased:        21,015 (ISIN: GB00BHJYC057)

 

Date of Purchases:       21 July 2025

 

 

 

Exhibit No: 99.5

 

24 July 2025

 

 

 

 

The Company announces that on 23 July 2025 it purchased the following number of its ordinary shares of 20340/399 pence each from Merrill Lynch International ("MLI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 18 February 2025 as announced on 18 February 2025.

 

 

Date of Purchase: 23 July

 

	London Stock Exchange	Cboe BXE	Cboe CXE	Turquoise	Aquis
Number of ordinary shares purchased	670	0	0	0	0
Highest price paid (per ordinary share)	£ 85.4800	£ 0.0000	£ 0.0000	£ 0.0000	£ 0.0000
Lowest price paid (per ordinary share)	£ 85.2400	£ 0.0000	£ 0.0000	£ 0.0000	£ 0.0000
Volume weighted average price paid (per ordinary share)	£ 85.3367	£ 0.0000	£ 0.0000	£ 0.0000	£ 0.0000

 

 

 

Following the above transaction, the Company has 154,506,544 ordinary shares in issue (excluding 6,206,782 held in treasury).

 

 

http://www.rns-pdf.londonstockexchange.com/rns/3224S_1-2025-7-23.pdf 

 

 

 

 

 

 

 

 

Shares purchased:        670 (ISIN: GB00BHJYC057)

 

Date of Purchases:       23 July 2025

 

 

 

Exhibit No: 99.6

 

25 July 2025

 

 

 

 

The Company announces that on 24 July 2025 it purchased the following number of its ordinary shares of 20340/399 pence each from Merrill Lynch International ("MLI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 18 February 2025 as announced on 18 February 2025.

 

 

Date of Purchase: 24 July

 

	London Stock Exchange	Cboe BXE	Cboe CXE	Turquoise	Aquis
Number of ordinary shares purchased	5,594	0	0	0	0
Highest price paid (per ordinary share)	£ 85.0000	£ 0.0000	£ 0.0000	£ 0.0000	£ 0.0000
Lowest price paid (per ordinary share)	£ 84.6800	£ 0.0000	£ 0.0000	£ 0.0000	£ 0.0000
Volume weighted average price paid (per ordinary share)	£ 84.8455	£ 0.0000	£ 0.0000	£ 0.0000	£ 0.0000

 

 

 

Following the above transaction, the Company has 154,500,950 ordinary shares in issue (excluding 6,206,782 held in treasury).

 

 

http://www.rns-pdf.londonstockexchange.com/rns/5180S_1-2025-7-24.pdf

 

 

 

 

 

 

 

 

 

Shares purchased:        5,594 (ISIN: GB00BHJYC057)

 

Date of Purchases:       24 July 2025

 

 

 

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

		InterContinental Hotels Group PLC
		(Registrant)
	By:	/s/ C. Bates
	Name:	C. BATES
	Title:	SENIOR ASSISTANT COMPANY SECRETARY
	Date:	25 July 2025